ASRS
TVRD

Arizona State Retirement System’s Tvardi Therapeutics TVRD Stock Holding History

Arizona State Retirement System’s Portfolio TVRD Stock Details TVRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-368
Closed -$65K – 2245
2023
Q1 		$65K Buy
368
+10
+3% +$3.35K ﹤0.01% 2167
2022
Q4 		$138K Buy
358
+14
+4% +$5.32K ﹤0.01% 2038
2022
Q3 		$116K Buy
344
+5
+1% +$1.81K ﹤0.01% 2062
2022
Q2 		$111K Buy
339
+18
+6% +$6.32K ﹤0.01% 2096
2022
Q1 		$140K Buy
321
+21
+7% +$8.62K ﹤0.01% 2094
2021
Q4 		$131K Sell
300
-3
-1% -$1.51K ﹤0.01% 2180
2021
Q3 		$169K Buy
303
+2
+0.7% +$1K ﹤0.01% 2109
2021
Q2 		$155K Sell
301
-82
-21% -$52K ﹤0.01% 2168
2021
Q1 		$299K Buy
383
+24
+7% +$16.4K ﹤0.01% 1817
2020
Q4 		$195K Sell
359
-14
-4% -$7.34K ﹤0.01% 1965
2020
Q3 		$171K Buy
373
+95
+34% +$55.2K ﹤0.01% 1825
2020
Q2 		$171K Buy
+278
New +$154K ﹤0.01% 1695

Other funds holding TVRD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
C
Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Arizona State Retirement System's TVRD Position: Q2 2023 in Review

Arizona State Retirement System sold out of Tvardi Therapeutics (TVRD) in Q2 2023, closing a stake of 368 shares — an estimated $65K sold.

Arizona State Retirement System first reported a position in TVRD in Q2 2020 and held it in 12 quarters. The position peaked at $299K in Q1 2021. 137 funds tracked by Wall St. Rank hold TVRD as of Q2 2023.

  • Arizona State Retirement System reported no remaining Tvardi Therapeutics position as of Q2 2023 after selling out during the quarter.
  • Arizona State Retirement System sold 368 Tvardi Therapeutics shares in Q2 2023, an estimated $65K.
  • Arizona State Retirement System first reported a position in Tvardi Therapeutics in Q2 2020 and held it in 12 quarters.
  • Arizona State Retirement System's Tvardi Therapeutics position peaked at $299K in Q1 2021.
  • 137 funds tracked by Wall St. Rank held Tvardi Therapeutics as of Q2 2023.

Based on Arizona State Retirement System's 13F filing for Q2 2023, filed 1 Aug 2023.